Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial.
Lai S, Li P, Liu X, Liu G, Xie T, Zhang X, Wang X, Huang J, Tang Y, Liu Z, Shen G, Li C, Lu F, Wang L, Jiang F, Sun C, Chen Y, Chen M.
Lai S, et al. Among authors: lu f.
Cancer Biol Med. 2024 Mar 4;21(5):433-44. doi: 10.20892/j.issn.2095-3941.2023.0373.
Cancer Biol Med. 2024.
PMID: 38445445
Free PMC article.
Clinical Trial.